IL1B rs16944: Understanding This Inflammatory Gene Variant
The rs16944 variant is a single nucleotide polymorphism located in the promoter region of the IL1B gene, which encodes a key pro-inflammatory cytokine. Research has investigated its potential influence on baseline inflammatory activity and its association with various health conditions, though evidence remains mixed and context-dependent.
What each genotype means
Baseline inflammatory response
This genotype is located in the promoter region of the IL1B gene, which helps regulate the production of the inflammatory protein interleukin-1 beta. Research into this variant is ongoing and results regarding its impact on specific health conditions are often mixed or vary significantly between different ancestral populations. Please consult with a healthcare professional if you have concerns about your inflammatory health.
The frequency of this genotype varies by ancestry, with the A allele being common in many global populations.
Baseline inflammatory response
This genotype is located in the promoter region of the IL1B gene, which helps regulate the production of the inflammatory protein interleukin-1 beta. Research into this variant is ongoing and results regarding its impact on specific health conditions are often mixed or vary significantly between different ancestral populations. Please consult with a healthcare professional if you have concerns about your inflammatory health.
This heterozygous genotype is frequently observed across major continental populations.
Baseline inflammatory response
This genotype is located in the promoter region of the IL1B gene, which helps regulate the production of the inflammatory protein interleukin-1 beta. Some studies have explored associations between this genotype and variations in antidepressant treatment response or susceptibility to certain inflammatory conditions, but findings remain inconsistent across different studies. Please consult with a healthcare professional if you have concerns about your inflammatory health or medication response.
The frequency of this genotype varies by ancestry, with the G allele being common in many global populations.
What is rs16944?
The rs16944 variant is a specific genetic change located on chromosome 2 within the IL1B gene. In genetic literature, it is often referred to as a promoter polymorphism, specifically situated at the -511 position. This means the variation occurs in a regulatory region of the DNA that helps determine how much of the IL-1β protein is produced by the cell. Because it sits in a control region rather than the protein-coding sequence itself, it is thought to influence the transcriptional activity of the gene. This can lead to differences in how an individual's immune system responds to stimuli, potentially altering the baseline levels of inflammation. Scientists study this SNP to understand why some people may have more robust or sensitive inflammatory responses compared to others.
The Role of the IL1B Gene
The IL1B gene provides instructions for making interleukin-1 beta, a potent cytokine that acts as a chemical messenger in the immune system. Produced primarily by activated macrophages, this protein is essential for initiating and regulating the inflammatory response. It plays a critical role in various biological processes, including cell proliferation, differentiation, and programmed cell death. Because it is a powerful mediator of inflammation, the body tightly regulates its production. When the system is working correctly, IL-1β helps the body fight off infections and heal injuries. However, when regulation is disrupted, excessive or prolonged production of this cytokine can contribute to chronic inflammatory conditions. Understanding how variants like rs16944 affect this gene's expression is a major focus of research into autoimmune and inflammatory diseases.
Research Associations and Evidence Strength
Research into rs16944 has explored its association with a wide range of conditions, including osteoarthritis, depression, and various autoimmune disorders. For instance, some studies have suggested that specific genotypes may correlate with differences in antidepressant treatment response or susceptibility to inflammatory conditions. However, it is important to note that the evidence strength for these associations is generally considered limited. Many findings are based on small sample sizes or specific ancestral populations, and results are often inconsistent across different studies. For example, while some research links the variant to disease risk, other studies have found no significant association. This variability is common in complex traits where many genes and environmental factors interact. Consequently, rs16944 should be viewed as one of many potential contributors to health outcomes rather than a definitive predictor of disease.
What You Can Do With This Information
Genetic information regarding variants like rs16944 is primarily for educational purposes and should not be used to make personal health decisions or diagnoses. Because the associations are often weak or conflicting, knowing your genotype for this SNP does not provide a clear roadmap for medical intervention. If you are concerned about inflammatory symptoms, chronic pain, or mental health, the most effective approach is to consult with a qualified healthcare professional. They can evaluate your symptoms, medical history, and lifestyle factors to provide appropriate care. If you are interested in how genetics might influence your response to specific medications, discuss this with your doctor or pharmacist. They can help you understand the current state of pharmacogenomics and whether genetic testing is relevant to your specific treatment plan.
How common is this variant?
The rs16944 variant is common, with a minor allele frequency of approximately 0.35 to 0.46 across major continental populations, meaning that all three genotypes are frequently observed in the general public.
Frequently asked questions
Is rs16944 a diagnostic test for disease?
No, rs16944 is not a diagnostic test. It is a common genetic variant associated with complex traits, and its presence does not confirm or rule out any medical condition.
Does my genotype mean I will have high inflammation?
Not necessarily. While the variant may influence gene expression, inflammation is a complex process regulated by many genes and environmental factors like diet, stress, and lifestyle.
Should I change my medication based on this SNP?
You should never change your medication based on genetic data alone. Always discuss your treatment plan and any concerns about medication response with your prescribing physician or pharmacist.
Why do studies show different results for this variant?
Genetic studies often show mixed results due to differences in study design, sample sizes, and the diverse genetic backgrounds of the populations being studied.
Sources & further reading
Educational information only, last refreshed 10/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs16944?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in IL1B
This SNP is recognized as a modifier of inflammatory response, potentially affecting responses to anti-TNF therapies.
Interleukin-1 beta variant associated with systemic inflammatory markers and potential modulation of dietary response.
Promoter variant (c.-511C>T) in the IL1B gene extensively studied for regulatory influence on interleukin-1 beta expression and chronic inflammatory states.
Promoter regulatory single-nucleotide variant in interleukin-1 beta associated with altered inflammatory cytokine secretion and chronic inflammation predisposition.
This variant is associated with altered cytokine production and susceptibility to inflammatory conditions.
This polymorphism in the interleukin-1 beta gene has been studied for its role in the pharmacogenomics of apremilast response in patients with psoriasis.